NASDAQ: PODD · Industrial Applications and Services · 4 alerts · CIK 1145197
Share price
$145.29Close, Nov 16
Market cap
$10.1B
Shares outstanding
69.37MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Insulet Corp filings on SEC EDGAR ↗
Insulet Corp reported total revenue of $842.0 million for the quarter ended September 30, 2026, a significant increase from $706.3 million in the prior year period. Net income rose to $141.1 million, or $2.03 per diluted share, driven by strong gross profit margins and the absence of related-party revenue dependencies seen in 2025.
Insulet reported Q3 2026 revenue of $842 million, a 19.2% increase year-over-year, driven by strong Omnipod sales in both U.S. and international markets. Alongside the earnings, the company announced a new $1 billion stock repurchase program authorized through 2028, with $400 million planned for the fourth quarter of 2026.
Insulet $725M Debt Financing with Morgan Stanley Senior Funding, Inc.
Insulet Corporation entered into a ninth amendment to its credit agreement to refinance $475 million in existing term loans with new term loans at a 0.25% lower interest rate margin. Additionally, the company increased its revolving credit facility commitments by $250 million to a total of $750 million and reduced the applicable interest rate margins for revolving loans.